TickerFacts.

CareDx, Inc. (CDNA): Share Repurchases

Annual figures by period end, from SEC filings.

$87.77M
Year ended 2025-12-31
$50.00M
Trailing 12 months to 2026-06-30
n/m
3-year compound annual growth
2020-12-31: $02021-12-31: $02022-12-31: $642.0K2023-12-31: $27.54M2024-12-31: $522.0K2025-12-31: $87.77M$87.77M
2020-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$87.77Mn/m2026-02-25, From 2025-01-01
2024-12-31$522.0K-98.1%2026-02-25, From 2024-01-01
2023-12-31$27.54Mn/m2026-02-25, From 2023-01-01
2022-12-31$642.0Kn/a2025-02-28, From 2022-01-01
2021-12-31$0n/a2024-02-28, From 2021-01-01
2020-12-31$0n/a2023-02-27, From 2020-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
CareDx, Inc. (CDNA)2025-12-31$87.77Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31$10.88Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$0-100.0%
Caris Life Sciences, Inc. (CAI)2025-12-31$113.0Kn/a
Guardant Health, Inc. (GH)2025-12-31$45.01Mn/a
Quest Diagnostics Inc (DGX)2025-12-31$450.00M+198.0%
Labcorp Holdings Inc. (LH)2025-12-31$450.00M+79.9%

Compare CDNA, FLGT, BLLN, CAI side by side · Screen every company in Services-Medical Laboratories ↗